B
DGX icon

Baird’s Quest Diagnostics DGX Stock Holding History

Baird’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.64M Buy
21,349
+12,620
+145% +$904K 0.02% 600
2014
Q4 		$586K Buy
8,729
+2,130
+32% +$134K 0.01% 890
2014
Q3 		$400K Sell
6,599
-29,059
-81% -$1.79M 0.01% 899
2014
Q2 		$2.09M Sell
35,658
-37,548
-51% -$2.2M 0.03% 480
2014
Q1 		$4.24M Buy
73,206
+462
+0.6% +$24.8K 0.06% 303
2013
Q4 		$3.9M Buy
72,744
+1,698
+2% +$101K 0.07% 308
2013
Q3 		$4.39M Buy
71,046
+1,426
+2% +$85.4K 0.08% 275
2013
Q2 		$4.22M Buy
+69,620
New +$4.15M 0.08% 270

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Baird's DGX Position: Q1 2015 in Review

Baird increased its Quest Diagnostics (DGX) stake by 145% in Q1 2015, buying an estimated $904K and bringing the position to 21,349 shares worth $1.64M. The position accounts for 0.02% of the portfolio, ranked #600.

Baird first reported a position in DGX in Q2 2013 and has held it in 8 quarters since. The position peaked at $4.39M in Q3 2013. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Baird held 21,349 shares of Quest Diagnostics worth $1.64M as of Q1 2015.
  • Baird bought 12,620 Quest Diagnostics shares in Q1 2015, an estimated $904K.
  • Quest Diagnostics made up 0.02% of Baird's portfolio in Q1 2015, its #600 holding.
  • Baird first reported a position in Quest Diagnostics in Q2 2013 and has held it in 8 quarters since.
  • Baird's Quest Diagnostics position peaked at $4.39M in Q3 2013.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.